Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 520

The DOI matches its Crossref record; 259 of the 259 references it cites were found in a registry or an index.

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

Open access
Osuchowski, Marcin F, Winkler, Martin S, Skirecki, Tomasz, Cajander, Sara, Shankar-Hari, Manu, Lachmann, Gunnar, Monneret, Guillaume, Venet, Fabienne, Bauer, Michael, Brunkhorst, Frank M, Weis, Sebastian, Garcia-Salido, Alberto, Kox, Matthijs, Cavaillon, Jean-Marc, Uhle, Florian, Weigand, Markus A, Flohé, Stefanie B, Wiersinga, W Joost, Almansa, Raquel, de la Fuente, Amanda, Martin-Loeches, Ignacio, Meisel, Christian, Spinetti, Thibaud, Schefold, Joerg C, Cilloniz, Catia, Torres, Antoni, Giamarellos-Bourboulis, Evangelos J, Ferrer, Ricard, Girardis, Massimo, Cossarizza, Andrea, Netea, Mihai G, van der Poll, Tom, Bermejo-Martín, Jesús F, Rubio, Ignacio·2021·The Lancet Respiratory Medicine

Abstract

The zoonotic SARS-CoV-2 virus that causes COVID-19 continues to spread worldwide, with devastating consequences. While the medical community has gained insight into the epidemiology of COVID-19, important questions remain about the clinical complexities and underlying mechanisms of disease phenotypes. Severe COVID-19 most commonly involves respiratory manifestations, although other systems are also affected, and acute disease is often followed by protracted complications. Such complex manifestations suggest that SARS-CoV-2 dysregulates the host response, triggering wide-ranging immuno-inflammatory, thrombotic, and parenchymal derangements. We review the intricacies of COVID-19 pathophysiology, its various phenotypes, and the anti-SARS-CoV-2 host response at the humoral and cellular levels. Some similarities exist between COVID-19 and respiratory failure of other origins, but evidence for many distinctive mechanistic features indicates that COVID-19 constitutes a new disease entity, with emerging data suggesting involvement of an endotheliopathy-centred pathophysiology. Further research, combining basic and clinical studies, is needed to advance understanding of pathophysiological mechanisms and to characterise immuno-inflammatory derangements across the range of phenotypes to enable optimum care for patients with COVID-19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-2600(21)00218-6

Cites

259 of 259 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 259 references

Cited by

See all 520

Metadata

Authors
Osuchowski, M. F., Winkler, M. S., Skirecki, T., Cajander, S., Shankar-Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M., Brunkhorst, F. M., Weis, S., Garcia-Salido, A., Kox, M., Cavaillon, J.-M., Uhle, F., Weigand, M. A., Flohé, S. B., Wiersinga, W. J., Almansa, R., de la Fuente, A., Martin-Loeches, I., Meisel, C., Spinetti, T., Schefold, J. C., Cilloniz, C., Torres, A., Giamarellos-Bourboulis, E. J., Ferrer, R., Girardis, M., Cossarizza, A., Netea, M. G., van der Poll, T., Bermejo-Martín, J. F., & Rubio, I.
Venue
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Published
2021-06
Volume
9
Issue
6
Pages
622-642
ISSN
2213-2600 (ISSN-L)
OpenAlex
W3162905796
Cited by
520
References
259
FWCI
36.50
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. https://app.cochat.ai/papers/10.1016/s2213-2600(21)00218-6
The paper
Osuchowski, M. F., Winkler, M. S., Skirecki, T., Cajander, S., Shankar-Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M., Brunkhorst, F. M., Weis, S., Garcia-Salido, A., Kox, M., Cavaillon, J.-M., Uhle, F., Weigand, M. A., Flohé, S. B., Wiersinga, W. J., Almansa, R., . . . Rubio, I. (2021). The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(21)00218-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.